Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at FMC's multiple
$0.4489.0% below market
0.94 ZNTL revenue / share×0.47x FMC P/S=$0.44
Market $3.99Implied $0.44
FMC · current priceP/S 0.47x
$12.97Latest market snapshot
Implied fair value · at ZNTL's multiple
$117.50805.9% above market
27.70 FMC revenue / share×4.24x ZNTL P/S=$117.50
Market $12.97Implied $117.50